Molina Healthcare, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on May 10, 2017, regarding the reconvened 2017 Annual Meeting of Stockholders for Molina Healthcare, Inc. The report was filed on May 15, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This document focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
At the reconvened meeting, 54,635,034 shares were voted, representing 95.80% of the 57,028,614 shares outstanding as of the March 9, 2017 record date. Stockholders approved the following proposals:
- Proposal 1 (Election of Directors): All three Class III nominees were elected. Dr. J. Mario Molina received 42,488,352 votes for; Ronna E. Romney received 38,979,676 votes for; and Dale B. Wolf received 45,738,241 votes for.
- Proposal 2 (Executive Compensation): Stockholders approved the compensation of named executive officers on a non-binding advisory basis with 40,078,859 votes for.
- Proposal 3 (Say-on-Pay Frequency): Stockholders approved conducting an advisory vote on executive compensation every one year, with 46,657,815 votes for the one-year option.
- Proposal 4 (Equity Incentive Plan): Stockholders approved the amendment and restatement of the 2011 Equity Incentive Plan and re-approved performance goals for Section 162(m)(1) awards with 39,335,463 votes for.
- Proposal 5 (Auditor Ratification): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2017 with 50,789,021 votes for.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on future performance, or specific risk factors. The document references the 2017 Proxy Statement for details regarding the Equity Incentive Plan.
Key Facts for Investor Verification
- Verify the specific terms of the Amended and Restated 2011 Equity Incentive Plan in the referenced 2017 Proxy Statement.
- Note the significant number of votes cast against the election of Ronna E. Romney (11,425,691) compared to other directors.
- Confirm the re-approval of Section 162(m)(1) performance goals to ensure compliance with tax deductibility limits for executive compensation.
- Review the 2017 Proxy Statement for the full description of the equity plan amendments approved by shareholders.